Pharmacokinetics, Pharmacodynamics, and Safety of Intravenous Efgartigimod and Subcutaneous Efgartigimod PH20 in Healthy Chinese Participants

Abstract Background Efgartigimod, a human immunoglobulin G (IgG)1-derived Fc fragment targeting the neonatal Fc receptor, has been developed into intravenous (IV) and subcutaneous (SC) formulations for treating generalized myasthenia gravis (gMG) and other autoimmune diseases. Data in the Chinese po...

Fuld beskrivelse

Bibliografiske detaljer

Principais autores:	Shan Jing, Yu Zhang, Yang Lin, Xiaowen Gu, Jing Liu, Antonio Guglietta, Jan Noukens, Tonke Van Bragt, Lina Wang, Jiajia Chen, Harald Reinhart, Xia Pu
Format:	Artigo
Sprog:	Inglês
Udgivet:	Adis, Springer Healthcare 2024-10-01
Serier:	Drugs in R&D
Online adgang:	https://doi.org/10.1007/s40268-024-00490-6
Tags:	Tilføj Tag Ingen Tags, Vær først til at tagge denne postø!